Court Denies Motion to Dismiss Claims Targeting a Biologic

The decision we report on today, Frye v. Novartis Pharms. Corp., 2022 WL 4305656 (E.D. Ark. 2022), leaves us shaking our heads. The court denied the…

Related Keywords

Novartis Pharms ,Andrew Tauber ,Supreme Court ,Winston Strawn ,Buckman Co ,Plaintiff Legal Committee ,Merck Sharp Dohme Corp ,Neovascular Age Related Macular ,Changes Being Effected ,Legal Committee ,Law ,Lawyers ,Legal ,Aw Firms ,Aw Updates ,Egal Updates ,Egal Developments ,Aw Developments ,Egal Newsletters ,Egal Current Awareness ,Deals ,Egal Advisers ,Egal Advisors ,Egal Directory ,Sa ,Ealthcare Amp Life Sciences ,